Breaks Categories: News

TuesdayJun 09, 2026 9:40 am

NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio’s Edge AI Kiosks Use Voice and AI to detect intoxication and fatigue. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the completion and delivery of its first prototype Edge AI Intoxication Detection Kiosks, a hardware and software platform designed to detect intoxication and fatigue through AI-powered voice analysis. The kiosks are intended for workplace environments and are being developed to help improve safety across industries where drug, alcohol and fatigue monitoring are critical. The company said the prototypes will now undergo testing,…

Continue Reading

TuesdayJun 09, 2026 9:30 am

NetworkNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Advances Arctic Exploration Program, Secures Halliburton Partnership

Greenland Energy (NASDAQ: GLND) provided a midyear operational update highlighting progress since its March 2026 Nasdaq debut, including the completion of a public offering that raised approximately $70 million in gross proceeds and the execution of key service agreements supporting its East Greenland exploration program. The company said it has signed a five-year drilling agreement with Stampede Drilling and an agreement with Halliburton (NYSE: HAL) for integrated consulting, logistics and well services ahead of its planned drilling campaign. Greenland Energy said it continues advancing procurement, infrastructure planning and equipment mobilization for its Jameson Land Basin project while targeting the start…

Continue Reading

TuesdayJun 09, 2026 9:20 am

NetworkNewsBreaks – BOXABL Unveils Conceptual UFO Habitat for Future Lunar and Planetary Settlements

Live on the Moon with BOXABL's UFO Space Habitat BOXABL highlighted UFO (Unidentified Folding Object), a conceptual off-world habitation system designed to address the challenges of transporting and deploying livable structures beyond Earth. The concept, featured in the company's recently released video "LIVE ON THE MOON (Part 1) — UFO by BOXABL," is based on foldable building intellectual property that would allow habitats to launch in a compact configuration and expand into larger living spaces after deployment. BOXABL UFO- Unidentified Folding Object BOXABL said the concept was developed by an after-hours skunkworks engineering team and is intended to support future…

Continue Reading

TuesdayJun 09, 2026 9:10 am

NetworkNewsBreaks – Bank of Japan Sees Growing Upside Inflation Risks Amid Middle East Tensions

CNW CurrenSees  Exploring the policies, markets and global events influencing currencies and the movement of money worldwide Bank of Japan Governor Kazuo Ueda said rising crude oil prices are creating upside risks to inflation and could spill over into a broader range of goods and services. The BOJ expects Japan's economy to continue growing despite higher energy costs, supported by strong corporate profits, wage growth and AI-related demand. Ueda indicated the central bank remains prepared to continue raising interest rates if inflation pressures prove more persistent than expected. June 9, 2026 – via  CurrencyNewsWire -- Bank of Japan Governor Kazuo Ueda…

Continue Reading

TuesdayJun 09, 2026 9:00 am

NetworkNewsBreaks – Bezos Says Space-Based Data Centers Are Coming, but Not Anytime Soon

NVIDIA Corp. (NASDAQ: NVDA) could eventually play a critical role in the development of orbital data centers, but Amazon founder Jeff Bezos believes the industry’s most optimistic timelines are unrealistic due to significant economic hurdles. Speaking about the future of space-based computing infrastructure, Bezos said that while data centers in orbit are likely to become a reality, the high cost of advanced AI chips and the expense of launching hardware into space remain major obstacles. Interest in orbital data centers continues to grow because they could leverage abundant solar energy and avoid the land-use challenges increasingly associated with terrestrial facilities. However,…

Continue Reading

MondayJun 08, 2026 2:49 pm

NetworkNewsBreaks – Roth Capital Partners to Host 16th Annual London Conference Featuring 80+ Growth Companies 

Roth Capital Partners will host its 16th Annual ROTH London Conference June 16-18, 2026, at the Four Seasons Hotel London at Park Lane, bringing together institutional investors and executives from more than 80 companies across the sustainability, technology, energy, digital infrastructure, engineering and mining sectors. The invitation-only event will feature one-on-one and small-group meetings designed to provide investors with direct access to company leadership teams and insight into growth strategies, operations and capital formation opportunities.  The conference agenda includes presentations from ARK Investment Management Founder and CEO Cathie Wood, ROTH Chief Economist Michael Darda and Chief Technical Strategist JC O'Hara. Organizers said discussions will focus on sectors…

Continue Reading

MondayJun 08, 2026 2:43 pm

NetworkNewsBreaks – Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) Secures Strategic Investment from VisionWave to Advance AI-Powered Defense Technologies 

Foresight (NASDAQ: FRSX) (TASE: FRSX) announced a definitive agreement with VisionWave Holdings (NASDAQ: VWAV) for a strategic equity investment of up to $17.5 million in VisionWave common stock, reflecting a post-investment valuation of approximately $34 million for Foresight. The companies plan to combine Foresight’s visible light, infrared and neuromorphic sensing technologies with VisionWave’s artificial intelligence and radio frequency-based perception systems to develop advanced solutions for defense and security applications. Under the agreement, VisionWave is expected to acquire a controlling 52% stake in Foresight through a two-stage transaction and gain representation on the company's board of directors, subject to shareholder and regulatory approvals. The collaboration is intended to accelerate the development and commercialization of AI-enhanced perception platforms…

Continue Reading

MondayJun 08, 2026 1:15 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in a virtual investor segment featuring Chief Financial Officer Steve O'Loughlin, who discussed the company's recently completed oversubscribed $22.5 million financing. The presentation focused on the factors supporting the successful capital raise following CNS Pharmaceuticals' strategic reset and acquisition-focused transformation. Management also addressed investor reception to the company's evolving strategy, the participation of healthcare-focused institutional investors and how the strengthened balance sheet positions CNS Pharmaceuticals to pursue potential transformational opportunities. The discussion highlighted the company's long-term growth strategy and efforts to create shareholder value as it advances its next phase of development. To…

Continue Reading

MondayJun 08, 2026 11:59 am

NetworkNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances European Commercial Launch Plans for GelrinC

Regentis Biomaterials (NYSE American: RGNT) announced plans to begin European surgeon training activities in the third quarter of 2026 as part of preparations for the commercial rollout of GelrinC(R), its CE Mark-approved treatment for knee cartilage lesions. The hands-on program will provide orthopedic surgeons with practical experience using the company's cell-free implant and is expected to begin at Humanitas Research Hospital in Milan, Italy, with additional sessions planned across Europe. The company said the training initiative is a key step in its European commercialization strategy and will be supported by a network of Centers of Excellence focused on surgeon education, clinical guidance and knowledge sharing. GelrinC is designed as…

Continue Reading

MondayJun 08, 2026 11:45 am

NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Advances Ibogaine Drug Development Program 

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.  Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) announced progress on its Ibogaine Initiative, securing naturally derived ibogaine from two sources in both hydrochloride and freebase forms. The company expects development of finished ibogaine drug products to begin this summer at its GMP-certified manufacturing facility in British Columbia, with plans to produce standardized 50 mg and 100 mg encapsulated dosage formats for research and regulated access programs. The update comes amid growing interest in ibogaine research and expanding public funding for psychedelic therapies, including a recently announced $50 million program in Texas. Optimi said its development program…

Continue Reading